Literature DB >> 6205136

Pharmacologic identification, activation and antagonism of two muscarine receptor subtypes in the lower esophageal sphincter.

R Gilbert, S Rattan, R K Goyal.   

Abstract

Lower esophageal sphincter pressures were monitored with water-filled catheters in anesthetized opossums. Muscarinic agonists McN-A-343 and bethanechol were administered in the arterial supply of the sphincter. McN-A-343 caused relaxation after a brief contraction of the sphincter. Bethanechol caused a dose-dependent contraction. Tetrodotoxin antagonized the inhibitory effect of McN-A-343 but did not antagonized sphincter contraction caused by McN-A-343 or bethanechol. The mean ED50 values were 6.9 nmol/kg i.a. for McN-A-343-induced relaxation, 10.5 nmol/kg i.a. for McN-A-343-induced contraction and 0.4 nmol/kg i.a. for bethanechol-induced contraction. Atropine caused a dose-dependent rightward shift in the dose-response curves of inhibitory and excitatory effects of the two muscarinic agonists. Pirenzepine caused a dose-dependent rightward shift in the dose-response curves of McN-A-343-induced relaxation. Pirenzepine did not modify sphincter contraction caused by the muscarinic agonists. 4-Diphenylacetoxy-N-methylpiperidine methiodide, on the other hand, did not modify McN-A-343-induced sphincter relaxation but caused dose-dependent rightward shifts in the dose-response curves of sphincter contraction caused by McN-A-343 or bethanechol. These studies suggest that there are two distinct types of muscarine receptors in the opossum lower esophageal sphincter. The M1 muscarine receptors are present on the inhibitory neurons and participate in the synaptic transmission between vagal preganglionic and intramural postganglionic inhibitory neurons. They are activated by McN-A-343 and antagonized by pirenzepine. The M2 muscarine receptors are located directly on the sphincter muscle. They are also activated by McN-A-343, but are selectively activated by bethanechol and are antagonized by 4-diphenylacetoxy-N-methylpiperidine methiodide.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205136

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  18 in total

1.  Subtypes of muscarinic receptors in vagal inhibitory pathway to the lower esophageal sphincter of the opossum.

Authors:  R J Gilbert; W J Dodds
Journal:  Dig Dis Sci       Date:  1987-10       Impact factor: 3.199

Review 2.  Muscarinic receptor regulation of the esophagus and lower esophageal sphincter.

Authors:  B Greenwood
Journal:  Dysphagia       Date:  1994       Impact factor: 3.438

3.  Cholinergic dysfunction in Shy-Drager syndrome: effect of the parasympathomimetic agent, bethanechol.

Authors:  R K Khurana
Journal:  Clin Auton Res       Date:  1994-04       Impact factor: 4.435

Review 4.  Regulation of basal tone, relaxation and contraction of the lower oesophageal sphincter. Relevance to drug discovery for oesophageal disorders.

Authors:  R Farré; D Sifrim
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

5.  Enhancement of guinea-pig intestinal peristalsis by blockade of muscarinic M1-receptors.

Authors:  H Schwörer; H Kilbinger
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

6.  Effect of secoverine on colonic myoelectric activity in diverticular disease of the colon.

Authors:  M Suchowiecky; D D Clarke; M Bhasker; R J Perry; W J Snape
Journal:  Dig Dis Sci       Date:  1987-08       Impact factor: 3.199

7.  Role of M1 muscarinic receptors in the parasympathetic control of colonic motility in cats and rabbits.

Authors:  F Blanquet; J Gonella
Journal:  J Physiol       Date:  1992-12       Impact factor: 5.182

8.  Interaction of selective compounds with muscarinic receptors at dispersed intestinal smooth muscle cells.

Authors:  E Barocelli; M Chiavarini; V Ballabeni; F Bordi; M Impicciatore
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

Review 9.  The irritable bowel syndrome.

Authors:  S M Collins
Journal:  CMAJ       Date:  1988-02-15       Impact factor: 8.262

10.  Effects of antireflux therapies on salivary function in normal humans.

Authors:  K R DeVault; D O Castell
Journal:  Dig Dis Sci       Date:  1987-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.